Alpha-1 Europe Alliance present at EMM 2025

Strengthening the voice of the Rare Disease Community in decision-making

Eurordis EMM 2025
The Alpha-1 Europe Alliance proudly participated in the EURORDIS Membership Meeting (EMM) 2025, held in Riga, Latvia, from 22–24 May, with over 140 participants. Representing the Alliance were Frank Willersinn, MD, Board Member of A1EA and President of Alpha-1 Plus Belgium, and Karin Schmid, President of Alpha-1 Switzerland, a member organisation of the Alliance.
Frank facilitated a workshop titled: “Volunteer Engagement Across the Medicine Lifecycle and Healthcare: Engaging with Stakeholders in the Development of Therapies as Representatives of the Rare Disease Community.” The session explored how patient organisations and volunteers can actively engage with key EU entities such as the European Medicines Agency (EMA) and European Reference Networks (ERNs). It offered valuable insights into how these institutions collaborate with patient representatives, helping organisations make informed decisions about their level of involvement and identify meaningful engagement opportunities in research, regulation, and care.

“For me as a co-actor in education explaining the European References Networks, I always find it amazing to sense how important these structures are for patient associations. At the same time, I realize how abstract and diverse their functioning can be, which needs a lot of understanding and time to get into it. The Eurordis Membership Meeting was the perfect opportunity to train future ePAG members!”

The three-day event offered a wide range of empowering sessions for patient organisations. Highlights included advocacy workshops, a showcase on Health Technology Assessment (HTA), practical guidance on using Rare Barometer survey results to strengthen advocacy efforts, and strategies to promote Community Advisory Boards (CABs) as a means to engage in and influence the research and development of new medicines.

For his part, Karin attended her first EURORDIS Membership Meeting and found it highly inspiring. She especially valued the workshops on mental health and advocacy, gaining practical tools to better support her community. She appreciated the clarity and motivation of the instructors. Karin left the meeting feeling empowered and eager to apply her new knowledge, particularly in using Rare Barometer data for advocacy.

2025.05.23_EURORDIS_2-43

"Overall, I learned a lot, and I’m grateful to the Alliance Europe for giving me the opportunity to explore these topics more deeply. I would love to keep learning and am excited to apply this new knowledge to support our members."

Beyond the formal sessions, it was a wonderful opportunity to reconnect with colleagues and friends, and to meet inspiring new peers from countries including Greece, Serbia, and Latvia.

Presentation slides from the meeting are available HERE. We hope these resources help support your continued advocacy for the rare disease community. 

The EURORDIS Membership Meeting (EMM) 2025 brought together patient advocates, healthcare professionals, and stakeholders from across Europe for a unique opportunity to connect, share experiences, and build collaborative initiatives.

This year’s theme, “Maximising Our Impact: Strengthening the Voice of the Rare Disease Community in Decision-Making,” focused on empowering patient organisations to actively participate in shaping health policies and care systems.

Over three interactive workshops, participants explored:

  • Advocacy at national and EU levels, gaining skills to influence policy and decision-making.
  • Volunteer involvement in the medicine lifecycle and healthcare, promoting active participation in research and care.
  • Using Rare Barometer results for advocacy, leveraging patient-generated data to drive evidence-based change.

Photos courtesy of EURORDIS.

Photographers: © Edgars Bruģis & Roberts Rēboks.

Share this post

Latest Posts

Alpha-1 Europe Alliance present at EMM 2025

Strengthening the voice of the Rare Disease Community in decision-making

Share this with your friends
Share this with your friends
Share this with your friends
Picture of alpha1europe
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
What happened and
whats up next

Alpha-1 Europe Alliance present at EMM 2025

Strengthening the voice of the Rare Disease Community in decision-making

Share this with your friends
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
Picture of alpha1europe